Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

PropertyValue
has major subject area list Child Behavior Disorders; Child Development Disorders, Pervasive; Cognition Disorders; Excitatory Amino Acid Antagonists; Memantine; Memory Disorders
has minor subject area list Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Glutamic Acid; Humans; Intelligence; Language Development Disorders; Male; Neuropsychological Tests; Prospective Studies; Treatment Outcome
information resource reference Owley T, Salt J, Guter S, Grieve A, Walton L, Ayuyao N, Leventhal BL, Cook EH. A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):517-24.
label A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

Search Criteria
  • Developmental
  • Disorders